Irinotecan/capecitabine versus cisplatin/capecitabine in advanced adenocarcinoma of the stomach or gastroesophageal junction: Interimsanalysis of a german AIO phase II study

被引：0
|
作者：
Moehler, M.
Kanzler, S.
Geissler, M.
Raedle, J.
Ebert, M.
Scherubl, H.
Flieger, D.
Seufferlein, T.
Galle, P. R.
Hoehler, T.
机构：
[1] Univ Mainz, Dept Med 1, D-6500 Mainz, Germany
[2] Univ Freiburg, Dept Med, D-7800 Freiburg, Germany
[3] Univ Homburg, Dept Med, D-6650 Homburg, Germany
[4] Univ Magdeburg, Dept Med, D-39106 Magdeburg, Germany
[5] Dept Med, Berlin, Germany
[6] Klinikum Aschaffenburg, Dept Med, Aschaffenburg, Germany
[7] Univ Ulm, Dept Med, D-89069 Ulm, Germany
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness Analysis of Fluorouracil, Leucovorin, and Irinotecan versus Epirubicin, Cisplatin, and Capecitabine in Patients with Advanced Gastric Adenocarcinoma
    Feng Wen
    Hanrui Zheng
    Yifan Wu
    John Wheeler
    Xiaoxi Zeng
    Ping Fu
    Qiu Li
    Scientific Reports, 6
  • [32] Cost-effectiveness Analysis of Fluorouracil, Leucovorin, and Irinotecan versus Epirubicin, Cisplatin, and Capecitabine in Patients with Advanced Gastric Adenocarcinoma
    Wen, Feng
    Zheng, Hanrui
    Wu, Yifan
    Wheeler, John
    Zeng, Xiaoxi
    Fu, Ping
    Li, Qiu
    SCIENTIFIC REPORTS, 2016, 6
  • [33] Cisplatin and capecitabine as first-line therapy for advanced gastric or gastronesophageal junction adenocarcinoma
    Viteri, A
    Barcelo-Galindez, R
    Rubio, I
    Fernandez, R
    Muñoz, A
    Fuente, N
    Perez-Hoyos, T
    Lopez-Argumedo, G
    Mañe, JM
    Lopez-Vivanco, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 360S - 360S
  • [34] Capecitabine and docetaxel in advanced gastric adenocarcinoma, an ongoing phase II study.
    Thuss-Patience, PC
    Kretzschmar, A
    Loew, A
    Massenkeil, G
    Pink, D
    Lebedinzew, B
    Micheel, S
    Dörken, B
    Reichardt, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 363S - 363S
  • [35] Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction
    Maarten J. Deenen
    Didier Meulendijks
    Henk Boot
    Marie-Cecile J. C. Legdeur
    Jos H. Beijnen
    Jan H. M. Schellens
    Annemieke Cats
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1285 - 1295
  • [36] A Phase II Study of Weekly Docetaxel in Combination with Capecitabine in Advanced Gastric and Gastroesophageal Adenocarcinomas
    Lo, Shelly S.
    Khorana, Alok A.
    Javle, Milind
    Simon, Sheryl
    Kiefer, Gauri
    Rajasenan, Kiran
    Wang, Hong
    Hantel, Alexander
    Shayne, Michelle
    Hwang, Jimmy
    Schmotzer, Amy
    Ramanathan, Ramesh K.
    ONCOLOGY, 2010, 78 (02) : 125 - 129
  • [37] Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction
    Deenen, Maarten J.
    Meulendijks, Didier
    Boot, Henk
    Legdeur, Marie-Cecile J. C.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Cats, Annemieke
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1285 - 1295
  • [38] THE TEX REGIMEN (DOCETAXEL, OXALIPLATIN AND CAPECITABINE) IN PATIENTS WITH ADVANCED OR METASTATIC GASTRIC AND GASTROESOPHAGEAL CANCER: RESULTS FROM A PHASE II TRIAL OF THE GERMAN AIO GROUP
    Thuss-Patience, P.
    Arnold, D.
    Stein, A.
    Grothe, W.
    Seufferlein, T.
    Reinacher-Schick, A.
    Geissler, M.
    Hofheinz, R.
    Moehler, M.
    Schmoll, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 90 - 90
  • [39] Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
    Lee, K. -W.
    Park, S. R.
    Oh, D. -Y.
    Park, Y. -I.
    Khosravan, R.
    Lin, X.
    Lee, S. -Y.
    Roh, E. -J.
    Valota, O.
    Lechuga, M. J.
    Bang, Y. -J.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1547 - 1558
  • [40] Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
    K.-W. Lee
    S. R. Park
    D.-Y. Oh
    Y.-I. Park
    R. Khosravan
    X. Lin
    S.-Y. Lee
    E.-J. Roh
    O. Valota
    M. J. Lechuga
    Y.-J. Bang
    Investigational New Drugs, 2013, 31 : 1547 - 1558
12345